In Vitro Models of Cell Senescence: A Systematic Review on Musculoskeletal Tissues and Cells
Abstract
:1. Introduction
2. Materials and Methods
2.1. Eligibility Criteria
2.2. Search Strategy
3. Results
3.1. In Vitro Techniques to Evaluate Cell Senescence
3.2. Nucleous Pulposus/Annulus Fibrous Cells and Disc Tissue
3.2.1. Pro-Inflammatory Cytokines
3.2.2. Mechanical Stimuli
3.2.3. Hydrogen Peroxide
3.2.4. Irradiation
3.3. Chondrocytes
3.3.1. Irradiation
3.3.2. Pro-Inflammatory Cytokines
3.3.3. Isolation from Damaged Cartilage
3.4. Myoblasts
3.4.1. Serum from Elderly Patients
3.4.2. Microgravity
3.5. Mesenchymal Stem Cells
3.5.1. Long Culture Passages
3.5.2. Pro-Inflammatory Cytokines
3.6. Senescence Treatments
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Sen, P.; Shah, P.P.; Nativio, R.; Berger, S.L. Epigenetic mechanisms regulating longevity and ageing. Cell 2016, 166, 822–839. [Google Scholar] [CrossRef] [PubMed]
- Kalampouka, I.; van Bekhoven, A.; Elliott, B.T. Differing Effects of Younger and Older Human Plasma on C2C12 Myocytes in Vitro. Front. Physiol. 2018, 9, 152. [Google Scholar] [CrossRef] [PubMed]
- Yasobant, S. Comprehensive public health action for our ageing world: The quintessence of public health policy. J. Int. Med. Res. 2018, 46, 555–556. [Google Scholar] [CrossRef] [PubMed]
- Li, Z.; Zhang, Z.; Ren, Y.; Wang, Y.; Fang, J.; Yue, H.; Ma, S.; Guan, F. Aging and age-related diseases: From mechanisms to therapeutic strategies. Biogerontology 2021, 22, 165–187. [Google Scholar] [CrossRef]
- Viña, J.; Borrás, C.; Miquel, J. Theories of ageing. IUBMB Life 2007, 59, 249–254. [Google Scholar] [CrossRef]
- Shadel, G.S.; Horvath, T.L. Mitochondrial ROS signaling in organismal homeostasis. Cell 2015, 163, 560–569. [Google Scholar] [CrossRef]
- Gorgoulis, V.; Adams, P.D.; Alimonti, A.; Bennett, D.C.; Bischof, O.; Bishop, C.; Campisi, J.; Collado, M.; Evangelou, K.; Ferbeyre, G.; et al. Cellular Senescence: Defining a Path Forward. Cell 2019, 179, 813–827. [Google Scholar] [CrossRef]
- Lopez-Otin, C.; Blasco, M.A.; Partridge, L.; Serrano, M.; Kroemer, G. The hallmarks of aging. Cell 2013, 153, 1194–1217. [Google Scholar] [CrossRef]
- Sharpless, N.E.; Sherr, C.J. Forging a signature of in vivo senescence. Nat. Rev. Cancer 2015, 15, 397–408. [Google Scholar] [CrossRef]
- He, S.; Sharpless, N.E. Senescence in Health and Disease. Cell 2017, 169, 1000–1011. [Google Scholar] [CrossRef]
- Vamvakas, S.S.; Mavrogonatou, E.; Kletsas, D. Human nucleus pulposus intervertebral disc cells becoming senescent using different treatments exhibit a similar transcriptional profile of catabolic and inflammatory genes. Eur. Spine J. 2017, 26, 2063–2071. [Google Scholar] [CrossRef] [PubMed]
- Zhu, Y.; Tchkonia, T.; Pirtskhalava, T.; Gower, A.C.; Ding, H.; Giorgadze, N.; Palmer, A.K.; Ikeno, Y.; Hubbard, G.B.; Lenburg, M.; et al. The Achilles’ heel of senescent cells: From transcriptome to senolytic drugs. Aging Cell 2015, 14, 644–658. [Google Scholar] [CrossRef]
- Tannenbaum, J.; Bennett, B.T. Russell and Burch’s 3Rs Then and Now: The Need for Clarity in Definition and Purpose. J. Am. Assoc. Lab. Anim. Sci. 2015, 54, 120–132. [Google Scholar] [PubMed]
- Jalal, S.; Dastidar, S.; Tedesco, F.S. Advanced models of human skeletal muscle differentiation, development and disease: Three-dimensional cultures, organoids and beyond. Curr. Opin. Cell Biol. 2021, 73, 92–104. [Google Scholar] [CrossRef] [PubMed]
- Cenini, G.; Hebisch, M.; Iefremova, V.; Flitsch, L.J.; Breitkreuz, Y.; Tanzi, R.E.; Kim, D.Y.; Peitz, M.; Brüstle, O. Dissecting Alzheimer’s disease pathogenesis in human 2D and 3D models. Mol. Cell. Neurosci. 2021, 110, 103568. [Google Scholar] [CrossRef]
- Park, Y.M.; Lee, M.; Jeon, S.; Hrůzová, D. In vitro effects of conditioned medium from bioreactor cultured human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) on skin-derived cell lines. Regen. Ther. 2021, 18, 281–291. [Google Scholar] [CrossRef]
- Luchena, C.; Zuazo-Ibarra, J.; Valero, J.; Matute, C.; Alberdi, E.; Capetillo-Zarate, E. A Neuron, Microglia, and Astrocyte Triple Co-culture Model to Study Alzheimer’s Disease. Front. Aging Neurosci. 2022, 14, 844534. [Google Scholar] [CrossRef]
- Kane, A.E.; Sinclair, D.A. Epigenetic changes during aging and their reprogramming potential. Crit. Rev. Biochem. Mol. Biol. 2019, 54, 61–83. [Google Scholar] [CrossRef]
- Li, X.; Lin, F.; Wu, Y.; Liu, N.; Wang, J.; Chen, R.; Lu, Z. Resveratrol attenuates inflammation environment-induced nucleus pulposus cell senescence in vitro. Biosci. Rep. 2019, 39, BSR20190126. [Google Scholar] [CrossRef]
- Li, P.; Gan, Y.; Xu, Y.; Wang, L.; Ouyang, B.; Zhang, C.; Luo, L.; Zhao, C.; Zhou, Q. 17beta-estradiol Attenuates TNF-α-Induced Premature Senescence of Nucleus Pulposus Cells through Regulating the ROS/NF-κB Pathway. Int. J. Biol. Sci. 2017, 13, 145–156. [Google Scholar] [CrossRef]
- Li, P.; Gan, Y.; Xu, Y.; Song, L.; Wang, L.; Ouyang, B.; Zhang, C.; Zhou, Q. The inflammatory cytokine TNF-α promotes the premature senescence of rat nucleus pulposus cells via the PI3K/Akt signaling pathway. Sci. Rep. 2017, 7, 42938. [Google Scholar] [CrossRef] [PubMed]
- Li, X.; Wu, A.; Han, C.; Chen, C.; Zhou, T.; Zhang, K.; Yang, X.; Chen, Z.; Qin, A.; Tian, H.; et al. Bone marrow-derived mesenchymal stem cells in three-dimensional co-culture attenuate degeneration of nucleus pulposus cells. Aging 2019, 11, 9167–9187. [Google Scholar] [CrossRef] [PubMed]
- Pang, L.; Li, P.; Zhang, R.; Xu, Y.; Song, L.; Zhou, Q. Role of p38-MAPK pathway in the effects of high-magnitude compression on nucleus pulposus cell senescence in a disc perfusion culture. Biosci. Rep. 2017, 37, BSR20170718. [Google Scholar] [CrossRef] [PubMed]
- Jiang, Y.; Dong, G.; Song, Y. Nucleus pulposus cell senescence is alleviated by resveratrol through regulating the ROS/NF-κB pathway under high-magnitude compression. Biosci. Rep. 2018, 38, BSR20180670. [Google Scholar] [CrossRef] [PubMed]
- Shi, J.; Pang, L.; Jiao, S. The response of nucleus pulposus cell senescence to static and dynamic compressions in a disc organ culture. Biosci. Rep. 2018, 38, BSR20180064. [Google Scholar] [CrossRef]
- Zhao, L.; Tian, B.; Xu, Q.; Zhang, C.; Zhang, L.; Fang, H. Extensive mechanical tension promotes annulus fibrosus cell senescence through suppressing cellular autophagy. Biosci. Rep. 2019, 39, BSR20190163. [Google Scholar] [CrossRef]
- He, J.; Zhang, A.; Song, Z.; Guo, S.; Chen, Y.; Liu, Z.; Zhang, J.; Xu, X.; Liu, J. The resistant effect of SIRT1 in oxidative stress-induced senescence of rat nucleus pulposus cell is regulated by Akt-FoxO1 pathway. Biosci. Rep. 2019, 39, BSR20190112. [Google Scholar] [CrossRef]
- Dimozi, A.; Mavrogonatou, E.; Sklirou, A.; Kletsas, D. Oxidative stress inhibits the proliferation, induces premature senescence and promotes a catabolic phenotype in human nucleus pulposus intervertebral disc cells. Eur. Cell. Mater. 2015, 30, 89–102. [Google Scholar] [CrossRef]
- Veroutis, D.; Kouroumalis, A.; Lagopati, N.; Polyzou, A.; Chamilos, C.; Papadodima, S.; Evangelou, K.; Gorgoulis, V.G.; Kletsas, D. Evaluation of senescent cells in intervertebral discs by lipofuscin staining. Mech. Ageing Dev. 2021, 199, 111564. [Google Scholar] [CrossRef]
- Kouroumalis, A.; Mavrogonatou, E.; Savvidou, O.D.; Papagelopoulos, P.J.; Pratsinis, H.; Kletsas, D. Major traits of the senescent phenotype of nucleus pulposus intervertebral disc cells persist under the specific microenvironmental conditions of the tissue. Mech. Ageing Dev. 2019, 177, 118–127. [Google Scholar] [CrossRef]
- Hamdi, D.H.; Chevalier, F.; Groetz, J.E.; Durantel, F.; Thuret, J.Y.; Mann, C.; Saintigny, Y. Comparable Senescence Induction in Three-dimensional Human Cartilage Model by Exposure to Therapeutic Doses of X-rays or C-ions. Int. J. Radiat. Oncol. Biol. Phys. 2016, 95, 139–146. [Google Scholar] [CrossRef] [PubMed]
- Copp, M.E.; Flanders, M.C.; Gagliardi, R.; Gilbertie, J.M.; Sessions, G.A.; Chubinskaya, S.; Loeser, R.; Schnabel, L.; Diekman, B. The combination of mitogenic stimulation and DNA damage induces chondrocyte senescence. Osteoarthr. Cartil. 2021, 29, 402–412. [Google Scholar] [CrossRef]
- Cao, X.; Luo, P.; Huang, J.; Liang, C.; He, J.; Wang, Z.; Shan, D.; Peng, C.; Wu, S. Intraarticular senescent chondrocytes impair the cartilage regeneration capacity of mesenchymal stem cells. Stem Cell Res. Ther. 2019, 10, 86. [Google Scholar] [CrossRef]
- Liu, Y.; Zhu, H.; Yan, X.; Gu, H.; Gu, Z.; Liu, F. Endoplasmic reticulum stress participates in the progress of senescence and apoptosis of osteoarthritis chondrocytes. Biochem. Biophys. Res. Commun. 2017, 491, 368–373. [Google Scholar] [CrossRef] [PubMed]
- Li, W.; Xiong, Y.; Chen, W.; Wu, L. Wnt/β-catenin signaling may induce senescence of chondrocytes in osteoarthritis. Exp. Ther. Med. 2020, 20, 2631–2638. [Google Scholar] [CrossRef] [PubMed]
- Wang, N.; He, Y.; Liu, S.; Makarcyzk, M.J.; Lei, G.; Chang, A.; Alexander, P.G.; Hao, T.; Padget, A.-M.; de Pedro, N.; et al. Engineering osteoarthritic cartilage model through differentiating senescent human mesenchymal stem cells for testing disease-modifying drugs. Sci. China Life Sci. 2022, 65, 309–327. [Google Scholar] [CrossRef] [PubMed]
- Allen, S.L.; Marshall, R.N.; Edwards, S.J.; Lord, J.M.; Lavery, G.G.; Breen, L. The effect of young and old ex vivo human serum on cellular protein synthesis and growth in an in vitro model of aging. Am. J. Physiol. Cell Physiol. 2021, 321, C26–C37. [Google Scholar] [CrossRef]
- Takahashi, H.; Nakamura, A.; Shimizu, T. Simulated microgravity accelerates aging of human skeletal muscle myoblasts at the single cell level. Biochem. Biophys. Res. Commun. 2021, 578, 115–121. [Google Scholar] [CrossRef]
- Li, X.C.; Wang, M.S.; Liu, W.; Zhong, C.F.; Deng, G.B.; Luo, S.J.; Huang, C.-M. Co-culturing nucleus pulposus mesenchymal stem cells with notochordal cell-rich nucleus pulposus explants attenuates tumor necrosis factor-α-induced senescence. Stem Cell Res. Ther. 2018, 9, 171. [Google Scholar] [CrossRef]
- Martinez-Pacheco, S.; O’Driscoll, L. Pre-Clinical In Vitro Models Used in Cancer Research: Results of a Worldwide Survey. Cancers 2021, 13, 6033. [Google Scholar] [CrossRef]
- Veronesi, F.; Contartese, D.; Borsari, V.; Pagani, S.; Fini, M.; De Mattei, M.; Tschon, M. Ageing and Osteoarthritis Synergically Affect Human Synoviocyte Cells: An In Vitro Study on Sex Differences. J. Clin. Med. 2022, 11, 7125. [Google Scholar] [CrossRef] [PubMed]
- Pagani, S.; Borsari, V.; Veronesi, F.; Ferrari, A.; Cepollaro, S.; Torricelli, P.; Filardo, G.; Fini, M. Increased Chondrogenic Potential of Mesenchymal Cells from Adipose Tissue Versus Bone Marrow-Derived Cells in Osteoarthritic In Vitro Models. J. Cell Physiol. 2017, 232, 1478–1488. [Google Scholar] [CrossRef] [PubMed]
- Gruber, H.E.; Hoelscher, G.L.; Ingram, J.A.; Norton, H.J.; Hanley, E.N., Jr. Increased IL-17 expression in degenerated human discs and increased production in cultured annulus cells exposed to IL-1ss and TNF-alpha. Biotech. Histochem. 2013, 88, 302–310. [Google Scholar] [CrossRef] [PubMed]
- Clerigues, V.; Guillen, M.I.; Castejon, M.A.; Gomar, F.; Mirabet, V.; Alcaraz, M.J. Heme oxygenase-1 mediates protective effects on inflammatory, catabolic and senescence responses induced by interleukin-1beta in osteoarthritic osteoblasts. Biochem. Pharmacol. 2012, 83, 395–405. [Google Scholar] [CrossRef]
- Newhauser, W.D.; Durante, M. Assessing the risk of second malignancies after modern radiotherapy. Nat. Rev. Cancer 2011, 11, 438–448. [Google Scholar] [CrossRef]
- Li, P.; Gan, Y.; Wang, H.; Zhang, C.; Wang, L.; Xu, Y.; Song, L.; Li, S.; Li, S.; Ou, Y.; et al. Dynamic compression effects on immature Nucleus Pulposus: A study using a novel intelligent and mechanically active bioreactor. Int. J. Med. Sci. 2016, 13, 225–234. [Google Scholar] [CrossRef]
- Li, P.; Gan, Y.; Xu, Y.; Song, L.; Wang, H.; Zhang, C.; Wang, L.; Zhao, C.; Luo, L.; Zhou, Q. Matrix homeostasis within the immature annulus fibrosus depends on the frequency of dynamic compression: A study based on the self-developed mechanically active bioreactor. Biomech. Model. Mechanobiol. 2017, 16, 385–394. [Google Scholar] [CrossRef]
- Tavakoli, J.; Elliott, D.M.; Costi, J.J. Structure and mechanical function of the inter-lamellar matrix of the annulus fibrosus in the disc. J. Orthopaedic. Res. 2016, 34, 1307–1315. [Google Scholar] [CrossRef]
- Wang, Z.; Wei, D.; Xiao, H. Methods of cellular senescence induction using oxidative stress. Methods Mol. Biol. 2007, 371, 179. [Google Scholar]
- Sellami, M.; Dhahbi, W.; Hayes, L.D.; Padulo, J.; Rhibi, F.; Djemail, H.; Chaouachi, A. Combined sprint and resistance training abrogates age differences in somatotropic hormones. PLoS ONE 2017, 12, e0183184. [Google Scholar] [CrossRef]
- Rittweger, J.; Albracht, K.; Flück, M.; Ruoss, S.; Brocca, L.; Longa, E. Sarcolab pilot study into skeletal muscle’s adaptation to long-term spaceflight. NPJ Microgravity 2018, 4, 18. [Google Scholar] [CrossRef] [PubMed]
- Lee, B.Y.; Han, J.A.; Im, J.S.; Morrone, A.; Johung, K.; Goodwin, E.C.; Kleijer, W.J.; DiMaio, D.; Hwang, E.S. Senescence-associated beta-galactosidase is lysosomal beta-galactosidase. Aging Cell. 2006, 5, 187–195. [Google Scholar] [CrossRef] [PubMed]
- Wang, F.; Cai, F.; Shi, R.; Wang, X.H.; Wu, X.T. Aging and age related stresses: A senescence mechanism of intervertebral disc degeneration. Osteoarthr. Cartil. 2016, 24, 398–408. [Google Scholar] [CrossRef] [PubMed]
- Mijit, M.; Caracciolo, V.; Melillo, A.; Amicarelli, F.; Giordano, A. Role of p53 in the Regulation of Cellular Senescence. Biomolecules 2020, 10, 420. [Google Scholar] [CrossRef] [PubMed]
- Safwan-Zaiter, H.; Wagner, N.; Wagner, K.D. P16INK4A-More Than a Senescence Marker. Life 2022, 12, 1332. [Google Scholar] [CrossRef]
- Sun, L.; Chiang, J.Y.; Choi, J.Y.; Xiong, Z.M.; Mao, X.; Collins, F.S.; Hodes, R.J.; Cao, K. Transient induction of telomerase expression mediates senescence and reduces tumorigenesis in primary fibroblasts. Proc. Natl. Acad. Sci. USA 2019, 116, 18983–18993. [Google Scholar] [CrossRef]
- Gao, X.; Yu, X.; Zhang, C.; Wang, Y.; Sun, Y.; Sun, H.; Zhang, H.; Shi, Y.; He, X. Telomeres and Mitochondrial Metabolism: Implications for Cellular Senescence and Age-related Diseases. Stem Cell Rev. Rep. 2022, 18, 2315–2327. [Google Scholar] [CrossRef]
- Liao, P.C.; Ng, L.T.; Lin, L.T.; Richardson, C.D.; Wang, G.H.; Lin, C.C. Resveratrol arrests cell cycle and induces apoptosis in human hepatocellular carcinoma Huh-7 cells. J. Med. Food 2010, 13, 1415–1423. [Google Scholar] [CrossRef]
- Gruber, H.E.; Yamaguchi, D.; Ingram, J.; Leslie, K.; Huang, W.; Miller, T.A.; Hanley, E.N., Jr. Expression and localization of estrogen receptor-beta in annulus cells of the human intervertebral disc and the mitogenic effect of 17-beta-estradiol in vitro. BMC Musculoskelet. Disord. 2002, 3, 4. [Google Scholar] [CrossRef]
- Ozcan, U.; Yilmaz, E.; Ozcan, L.; Furuhashi, M.; Vaillancourt, E.; Smith, R.O.; Görgün, C.Z.; Hotamisligil, G.S. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 2006, 313, 1137–1140. [Google Scholar] [CrossRef]
Cells/Tissue | In Vitro Model of Senescence | Evaluations | Main Results | Ref. |
---|---|---|---|---|
NP cells from healthy SD rats (6–8 wks old) | Group 1: cells; Group 2: cells + TNFα (20 ng/mL) and IL1β (20 ng/mL) | Cell proliferation (CCK8 assay); Cell senescence (SA-β-Gal staining); Cell cycle (Flow cytometry); TE activity (ELISA); ROS content (ROS assay); AGG, COLL II, p53, p16, MMP3, MMP13, ADAMTS4 gene expression (RT-PCR); AGG, COLL II proteins (ICC); p16, p53 proteins (WB) | Group 2: ↑ ROS content, SA-β-Gal, G0/G1 phase, p16, p53, MMP3, MMP13 and ADAMTS4 expression; ↓ cell viability, TE activity, S phase, AGG, and COLL II proteins than group 1 | Li et al., 2019 [19] |
NP cells and discs from healthy SD rats (6–8 wks old) | Group 1: cells; Group 2: cells + TNFα (10 ng/mL); Group 3: discs; Group 4: discs + TNFα (200 ng/mL) | Cell proliferation (CCK8 assay); Cell senescence (SA-β-Gal staining); Cell cycle (Flow cytometry); TE activity, ROS content (ELISA); p16, p53, AGG, COLL II gene expression (RT-PCR); AGG, COLL II, ERα, ERβ proteins (ICC); p16, p53, AGG, COLL II, NF-κB p65, p-NF-κB p65, ERα, ERβ proteins (WB); GAG, HYP content; AGG, COLL II proteins (IHC) | Groups 2, 4: ↓ cell viability, TE activity, AGG and COLL II proteins; ↑ SA-β-Gal, ROS, and p53 and p16 proteins than groups 1, 3 | Li et al., 2017 [20] |
NP cells from healthy SD rats (6–8 wks old) | Group 1: cells; Group 2: cells + TNFα (10, 20, 40 ng/mL); Group 3: cells + TNFα (10 ng/mL) + recovery in normal culture conditions; Group 4: cells + TNFα (10 ng/mL) without recovery | Cell proliferation (CCK8 assay); Cell viability (LIVE/DEAD); Cell senescence (SA-β-Gal staining); Cell cycle (Flow cytometry); TE activity (ELISA); p53, p16, AGG, COLL II, AKT gene expression (RT-PCR); GAG content (DMMB assay); AGG, COLL II proteins (ICC) | Groups 2, 4: ↓ cell proliferation, TE activity, AGG and COLL II proteins; ↑ p53, p16, and AKT expression than group 1 in a dose-dependent manner. Group 3: similar results than group 4 | Li et al., 2017 [21] |
NP cells from healthy SD rats (4 wks old); BMSCs from healthy SD rats (4–5 days old) | Group 1: cells + blank calcium alginate gel balls; Group 2: cells treated with TNFα (20 ng/mL) + blank calcium alginate gel balls; Group 3: cells treated with TNFα (20 ng/mL) + calcium alginate gel balls with BMSCs; Group 4: cells treated with TNFα (20 ng/mL) + calcium alginate gel balls with NP cells | Cell viability (CCK8 assay); Cell senescence (SA-β-Gal staining); Cell cycle (Flow cytometry); p16, p21, p53 gene expression (RT-PCR); COLL II, MMP9, ZMPSTE24, RelA proteins (IF) | Groups 2, 4: ↑ SA-β-Gal than groups 1, 3. Groups 2, 4: ↑ SA-β-Gal, MMP9 protein, p16, p21, and p53 expression; ↓ ZMPSTE24 protein than group 3 | Li et al., 2019 [22] |
Discs of healthy pigs (3–4 mo old) | Group 1: discs; Group 2: discs + intermittent compression (0.1 MP at 1.0 Hz for 2 hrs) + perfusion-culture; Group 3: discs + intermittent compression (1.3 MP at 1.0 Hz for 2 hrs) + perfusion-culture | Cell senescence (SA-β-Gal staining); PG distribution (Alcian Blue staining); AGG, COLL II, TIMP1, TIMP3, ADAMTS4, MMP3, p16, p53 gene expression (RT-PCR); p38, p-p38, p16, p53 proteins (WB); AGG, COLL II, PCNA proteins (IHC); GAG, HYP content (Biochemical measurement) | Group 3: ↑ SA-β-Gal, p38, p-p38, p16, p21, p53, ADAMTS4, and MMP3 proteins; ↓ AGG, COLL II, GAG, HYP, and PCNA proteins, TIMP3 expression than groups 1, 2 | Pang et al., 2017 [23] |
NP cells from healthy SD rats (7–8 wks old), suspended in collagen solution and seeded into DBM | Group 1: cells; Group 2: cells + 20% dynamic compression (1.0 Hz for 6 hrs/day) | Cell proliferation (CCK8 assay); Cell senescence (SA-β-Gal staining); Cell cycle (Flow cytometry); TE activity, ROS content (ELISA); p16, p53 gene expression (RT-PCR); p16, p53, NF-κB p65, p-NF-κB p65 proteins (WB) | Group 2: ↓ cell proliferation; ↑ SA-β-Gal, p53, p16, and NF-κB proteins, ROS content than group 1 | Jiang et al., 2018 [24] |
Discs from healthy pigs (12–13 mo old) | Group 1: discs; Group 2: discs + static compression (0.4 MP at 1.0 Hz for 4 hrs/day); Group 3: discs + dynamic compression (0.4 MP at 1.0 Hz for 4 hrs/day) | Cells senescence (SA-β-Gal staining); TE activity (ELISA); AGG, COLL II, p16, p53 gene expression (RT-PCR); COLL II, AGG proteins (IHC); p53, p16 proteins (WB); GAG, HYP content (Biochemical measurement) | Group 2: ↑ SA-β-Gal, p16 and p53 proteins; ↓ TE activity, AGG, COLL II, GAG, and HYP proteins than groups 1, 3. Group 3: ↓ SA-β-Gal, p16 and p53 proteins; ↑ TE activity, AGG, COLL II, GAG, and HYP proteins than groups 1, 2 | Shi et al., 2018 [25] |
AF cells from healthy SD rats (3 mo old) | Group 1: cells; Group 2: cells + 5% elongation (1 Hz for 8 hrs/day); Group 3: cells + 20% elongation (1 Hz for 8 hrs/day) | Cell proliferation (CCK8 assay); Cell cycle (Flow cytometry); TE activity (ELISA); AGG, COLL II, BCL1, LC3, p53, p16 gene expression (RT-PCR); p16, p53, AGG, COLL II, BCL1, LC3 proteins (WB) | Group 1: similar results than group 2; Group 3: ↓ cell proliferation, TE activity, S phase, AGG, COLL II, BCL1, and LC3 proteins; ↑ G0/G1 phase, p16, and p53 proteins than groups 1, 2 | Zhao et al., 2019 [26] |
NP cells from healthy SD rats (8 wks old) | Group 1: cells; Group 2: cells + H2O2 (0.05–0.15 mM) | Cell morphology (H/E, toluidine blue staining); Cell proliferation (CCK8 assay); Cell senescence (SA-β-Gal staining); Nuclear morphology (Hoechst staining); ROS level; Cell cycle, apoptosis (Flow cytometry); TNFα, IL1β, IL6, IL8 gene expression (RT-PCR); p53, p21, p16 proteins (WB) | Group 2: ↑ SA-β-Gal, p53, p21, and p16 proteins, TNFα, IL1β, IL6, and IL8 expression; ↓cell viability and proliferation than group 1 | He et al., 2019 [27] |
NP cells from healthy subjects (nr) | Group 1: cells; Group 2: cells + H2O2 (0–2 mM) | ROS kinetics (DCFH-DA assay); Cell viability (MTT assay); Cell proliferation (DNA synthesis assay); Cell cycle (Flow cytometry); Cell senescence (SA-β-gal staining); Telomere length; p16, p21 Catalase, SOD, COX2, ADAMTS4, ADAMTS5, MMP1, MMP2, MMP9, MMP13, TIMP1, TIMP2, TIMP3, ACAN, Biglycan, Decorin, Versican gene expression (RT-PCR); PARP, p-p38, p38, p-SAPK/JNK, SAPK/JNK, p-AKT, AKT, p-Chk2, p-p53, p-ERK1/2, panERK, p21, p-ATM, p53, p16, pRb proteins (WB); p-H2A.X (IF) | Group 2: ↑ ROS; ↓ cell proliferation than group 1. Group 2 at 0.5 mM: ↑ p-38, H2A.X, and p53 proteins, SA-β-gal, ROS, and ECM-degrading enzymes; ↓ ECM structural components | Dimozi et al., 2015 [28] |
NP and AF cells of healthy Wistar rats (2 mo old); NP and AF cells from healthy Wistar rats (2 and 22 mo old); NP and AF cells from pz with disc herniation (nr); NP and AF cells from healthy subjects (nr) | Group 1: cells from pz; Group 2: cells from pz + γ-ray (60Co gamma, 2 Gy/min); Group 3: cells from young rats + γ-ray (60Co gamma, 2 Gy/min); Group 4: cells from old rats + γ-ray (60Co gamma, 2 Gy/min); Group 5: cells from healthy individuals + γ-ray (60Co gamma, 2 Gy/min) | Cell proliferation (BrdU incorporation assay); Cell senescence (SA-β-gal staining); GL13 protein (ICC); p16, GL13 proteins (IHC) | Group 2: ↓ cell proliferation; ↑ SA-β-gal, GL13 proteins than group 1. Group 4: ↑ SA-β-gal, GL13 protein than group 3. Group 2: ↑ p16, GL13 proteins than group 5 | Veroutis et al., 2021 [29] |
NP cells from healthy bovine (nr) | Group 1: cells; Group 2: cells + 10% FBS, 4.5 mg/mL glucose, 300 mOsm/kg H2O, 20% O2 + γ-ray (60Co gamma, 2.5 Gy/min); Group 3: cells + serum-free, 0.9 mg/mL glucose, 400 mOsm/kg H2O, 2% O2 + γ-ray (60Co gamma, 2.5 Gy/min) | Cell proliferation (BrdU incorporation); Cell senescence (SA-β-Gal staining); p16, p21, ICAM1, MMP1, MMP2, MMP3, ADAMTS4, ADAMTS5, AGG, COLL II gene expression (RT-PCR) | Group 2: ↓ cell proliferation, ↑ SA-β-Gal than group 1. Groups 2, 3: ↑ p16, p21, ICAM1, MMP1, MMP2, MMP3, AGG, and MMP1 expressions; ↓ COLL II expression than group 1 | Kouroumalis et al., 2019 [30] |
Purchased human Chons | Group 1: cells + monoenergetic C-ions (75–95 MeV/mm); Group 2: cells + X-ray (225 kV, 13 mA); Group 3: cells in collagen scaffold + monoenergetic C-ions (75–95 MeV/mm); Group 4: cells in collagen scaffold + X-ray (225 kV, 13 mA) | Cell proliferation (Flow cytometry); Cell toxicity (Bioluminescent cytotoxicity assay); Cell senescence (SA-β-gal staining); Cell apoptosis (Flow cytometry); COX2, p21, Caspase-3 proteins (WB) | Group 1: ↓ cell viability than group 2. Groups 1, 3: ↑ SA-β-gal than groups 2, 4. Groups 3, 4: ↑ p21; ↓ COX2 than groups 1, 2 | Hamdi et al., 2015 [31] |
Chons from healthy horses (4–7 yrs old); Chons from cadavers (38–73 yrs old) | Group 1: cells; Group 2: cells + γ-ray (10 Gy); Group 3: cells + TGFβ1 and bFGF; Group 4: cells + γ-ray (10 Gy) + TGFβ1 and bFGF | Cell senescence (SA-β-gal staining); MMP13, IL6, IGFBP3, CCL2 gene expression (RT-PCR); p16, γH2AX proteins (IF) | Group 2: ↑ SA-β-gal, p16, γH2AX than group 1; Group 4: ↑ SA-β-gal, γH2AX, and p16 proteins, IGFBP3 and CCL2 gene expressions than groups 2, 3 | Copp et al., 2021 [32] |
BMSCs from healthy SD rats (3 wks old); Chons from healthy SD rats (3 wks old) | Group 1: BMSCs; Group 2: Chons; Group 3: BMSCs + Chons; Group 4: Chons + γ-ray (1.080 Gy/min for 10 min); Group 5: BMCs + Chons + γ-ray (1.080 Gy/min for 10 min) | Cell proliferation (EdU incorporation assay); Cell senescence (SA-β-Gal staining); Bax, Bcl-2, CDKN2A, CDKN1A, IL6, MMP1, MMP13, Sox9, IL1β, Coll II, Nanog, Oct-4 gene expression (RT-PCR); Caspase-3 protein (IHC); COLL II, AGG proteins (WB) | Group 4: ↑ SA-β-Gal, IL6 and MMP13 expression, Caspase-3 protein; ↓ proliferation, Bax/Bcl2, IL1β and COLL II expression than group 2. Group 5: ↓ proliferation, COLL II gene expression and protein; ↑ Caspase-3 protein, Bax/Bcl2, Oct4 and Nanog expression, SA-β-Gal, AGG protein than groups 1, 3 | Cao et al., 2019 [33] |
Chons from healthy subjects (28–59 yrs old) | Group 1: cells; Group 2: cells cultured for 24 hrs + IL1β (10 ng/mL) | Cell proliferation (CCK8 assay); Cell apoptosis (Flow cytometry); Cell senescence (SA-β-gal staining); COLL II, ADAMTS5, MMP13 gene expression (RT-PCR); GRP78 protein (WB) | Group 2: ↓ COLL II expression; ↑ ADAMTS5 and MMP13 gene expressions, GRP78 protein than group 1 | Liu et al., 2017 [34] |
Chons from NZW rabbits (1 mo old) and rats (2 wks old) | Group 1: rabbit cells + serum-starved overnight conditions + DKK1 (100 ng/mL) + IL1β (10 ng/mL); Group 2: rabbit cells + serum-starved overnight conditions + LiCl (20 mM) + IL1β (10 ng/mL); Group 3: rabbit cells; Group 4: rat cells + serum-starved overnight + Wnt-1 (10 ng/mL); Group 5: rat cells; Group 6: rat cells + serum-starved overnight + Wnt-1 (10 ng/mL) + IL1β (10 ng/mL); Group 7: rat cells + serum-starved overnight + Wnt-1 (10 ng/mL) + PBS | Cell senescence (SA-β-gal staining); MMP13, p53, 18s rRNA, MMP3 gene expression (RT-PCR); β-catenin, MMP13, MMP3, p16, p53, acetylated p53, SIRT-1 proteins (WB) | Group 2: ↑ β-catenin, MMP13, and acetylated p53, SIRT-1 proteins than group 1. Group 4: ↑ cell senescence, p53, and p16 proteins than group 5. Group 6: ↑ MMP3 and MMP13 proteins than group 7 | Li et al., 2020 [35] |
Chons from cartilage of preserved (P-C) and severely damaged (D-C) areas of OA pz (nr) | Group 1: Chons micromasses from P-C; Group 2: Chons micromasses from D-C | Cell proliferation (Flow cytometry); Cell senescence (SA-β-gal staining); Telomere length (TAT assay); p16INK4a, p21, p53, COLL II, SOX9, AGG, Ats4, Ats5, MMP12, MMP13, COLL I, COLL III, VCAN, IL6, IL8, p16, SA-β-gal gene expression (RT-PCR); p16INK4a, MMP13 proteins (IHC); COLL II, p16INK4a proteins (IF); SOX9, MMP13, p21, p53, p16 proteins (WB); GAG content (Safranin O/Fast green staining) | Group 2: ↓ cartilage matrix deposition, telomere length, COLL II, SOX9, and AGG expression; ↑ MMP13, p16, p21, and p53 proteins and expressions than group 1 | Wang et al., 2022 [36] |
Purchased C2C12 (10th–12th in vitro passages) | Group 1: myotubes; Group 2: myotubes + 10% of serum of fasted young donors; Group 3: myotubes + 10% of serum of old donors | Desmin protein (ICC); IgG2a monoclonal antipuromycin, p-mTOR, mTOR, p-Akt, Akt, p-p70S6K1, p70S6K1, p-4EBP-1, 4EBP1, p-RPS-6, RPS-6, p-eEF2, eEF2, LC3A/B, Caspase-3, MuRF-1, F-box (WB) | Group 2: ↑ myotube diameter and NFI, Akt, p70S6K1, and eEF2 proteins than groups 1, 3. Group 3: ↓ Myotube diameter than group 1 | Allen et al., 2021 [37] |
Purchased C2C12 cells | Group 1: cells + 5% plasma from young subjects; Group 2: cells + 5% plasma from old subjects | Cell proliferation (cell counter); Scratch assay; Cell diameter | Group 1: ↓ scratch size; ↑ cell diameter, proliferation than group 2 | Kalampouka et al., 2018 [2] |
Purchased human myoblasts | Group 1: cells at 1st passage + simulated microgravity (1 × 10−3 G; µG); Group 2: cells at 1st passage + normal gravity (1 G); Group 3: cells at 5th passage + normal gravity (1 G) | Cell proliferation assay; Cell senescence (SA-β-Gal activity); Desmin, Myf5 proteins (ICC); Cytoskeleton areas and nuclei analysis; Differentiation into myotubes (IF for MHC) | Groups 2, 3: ↑ MHC and desmin proteins, myotubes diameter, cell proliferation; ↓ Myf5 protein than group 1. Groups 1, 3: ↑ SA-β-Gal than group 2 | Takahashi et al., 2021 [38] |
BMSCs from OA pz | Group 1: cells at 10th passage; Group 2: cells at 4th passage | Tri-lineage differentiation; CFU assay; Cell proliferation (Flow cytometry, MTT); Cell senescence (SA-β-gal staining); Telomere length (TAT assay); p16, MMP13 proteins (IHC); p16, p21, p53, COLL II, SOX9, AGG, Ats4, Ats5, MMP12, MMP13, COLL I, COLL III, VCAN, IL6, IL8, SA-β-gal gene expression (RT-PCR); COLL II, p16 proteins (IF); SOX9, MMP13, p21, p53, p16INK4a proteins (WB) | Group 1: ↓ proliferation, differentiation potential, telomere length, COLL II, SOX9, and AGG expressions and proteins; ↑ p16, SA-β-gal, MMP13, p21, and p53 expressions and proteins than group 2 | Wang et al., 2022 [36] |
NPMSCs from pz (37–52 yrs old) | Group 1: cells; Group 2: cells + TNFα (10 ng/mL) | Cell viability (Calcein-AM); Cell senescence (SA-β-Gal staining); Cell proliferation (CCK8 assay); p16, p21, p53, IL6, MMP13, ADAMTS5, brachyury, FOXF1, Pax1, CA12, HIF1α, COLL Iα1, COLL IIα1, SOX9, AGG, LPL, PPAR2, ALP, Runx2 gene expression (RT-PCR); COLL II, CA12 proteins (IF, WB); GAG content (DMMB assay) | Group 2: ↑ senescent cell morphology, SA-β-Gal, p16, p21, p53, IL6, MMP13, and ADAMTS5 expressions than group 1 | Li et al., 2018 [39] |
Group (CTR) | Treatment | Main Results | Ref. |
---|---|---|---|
NP cells + TNFα (20 ng/mL) and IL1β (20 ng/mL) | NP cells + TNFα (20 ng/mL) and IL1β (20 ng/mL) + resveratrol (100 µM) | Resveratrol: ↓ ROS, SA-β-Gal, G0/G1 phase, p16, p53, MMP3, MMP13, and ADAMTS4 proteins; ↑ cell proliferation, S phase, TE activity, AGG, and COLL II proteins than CTR | Li et al., 2019 [19] |
NP cells + 20% dynamic compression (1.0 Hz for 6 hrs/day) | NP cells + 20% dynamic compression (1.0 Hz for 6 hrs/day) + resveratrol (30 μM or 60 µM) | Resveratrol: ↑ cell proliferation; ↓ SA-β-Gal, p53, p16, and NF-κB proteins, ROS content than CTR | Jiang et al., 2018 [24] |
NP cells or discs + TNFα (10 ng/mL) | NP cells or discs + TNFα (10 ng/mL) + E2 (10−7 M); NP cells + TNFα (10 ng/mL) + E2 (10−7 M) + ICI 182,780 (10 μM) | E2: ↑ cell proliferation, TE activity, AGG and COL II proteins; ↓ SA-β-Gal, ROS, p53, and p16 proteins than CTR and E2 + ICI182780 | Li et al., 2017 [20] |
NPMSCs + TNFα (10 ng/mL) | NPMSCs + TNFα (10 ng/mL) + rabbit NC-rich NP explant | NC-rich NP explant: ↑ cell proliferation, CA12, FOXF1, Pax-1, AGG, SOX-9, and COLL II proteins; ↓ COLL I protein than CTR | Li et al., 2018 [39] |
Chons + IL1β (10 ng/mL) | Chons + IL1β (10 ng/mL) + 4-PBA (100 µM) | 4-PBA: ↓ GRP78 protein, SA-β-gal, apoptosis; ↑ cell viability than CTR | Liu et al., 2017 [34] |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Veronesi, F.; Contartese, D.; Di Sarno, L.; Borsari, V.; Fini, M.; Giavaresi, G. In Vitro Models of Cell Senescence: A Systematic Review on Musculoskeletal Tissues and Cells. Int. J. Mol. Sci. 2023, 24, 15617. https://doi.org/10.3390/ijms242115617
Veronesi F, Contartese D, Di Sarno L, Borsari V, Fini M, Giavaresi G. In Vitro Models of Cell Senescence: A Systematic Review on Musculoskeletal Tissues and Cells. International Journal of Molecular Sciences. 2023; 24(21):15617. https://doi.org/10.3390/ijms242115617
Chicago/Turabian StyleVeronesi, Francesca, Deyanira Contartese, Laura Di Sarno, Veronica Borsari, Milena Fini, and Gianluca Giavaresi. 2023. "In Vitro Models of Cell Senescence: A Systematic Review on Musculoskeletal Tissues and Cells" International Journal of Molecular Sciences 24, no. 21: 15617. https://doi.org/10.3390/ijms242115617